TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Fusen Pharmaceutical Co., Ltd. ( (HK:1652) ).
Fusen Pharmaceutical Co., Ltd. has announced a discloseable transaction involving the sale of its entire equity interests in Henan Fusen Intelligent Energy Conservation Technology Company Limited. The transaction is valued at RMB73.0 million and involves a conditional agreement with a purchaser owned by state and local government authorities in China. This strategic move is part of Fusen Pharmaceutical’s efforts to streamline its operations and focus on its core business areas. The disposal is subject to certain conditions and regulatory requirements, and stakeholders are advised to exercise caution.
The most recent analyst rating on (HK:1652) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Fusen Pharmaceutical Co., Ltd. stock, see the HK:1652 Stock Forecast page.
More about Fusen Pharmaceutical Co., Ltd.
Average Trading Volume: 1,960,742
Technical Sentiment Signal: Buy
Current Market Cap: HK$713.2M
See more insights into 1652 stock on TipRanks’ Stock Analysis page.